Excelya is an independent European CRO founded in 2014, providing full-service, FSP and resourcing clinical research solutions to Biotech, Pharma and Medical Device organizations across 28 countries.
Excelya is an independent European Contract Research Organization (CRO) founded in 2014, providing full-service clinical research solutions to Biotech, Pharma, and Medical Device organizations. The company employs more than 1,000 experts and operates across 28 countries, with a presence in Europe, the USA and India. Its work covers clinical research and clinical trial management across a range of therapeutic areas, including oncology, hematology, rare disease, pediatrics, inflammation and immunology, infectious disease and vaccines, pain treatment and CNS, as well as late-phase studies and real-world evidence.
The firm delivers its services through three models: a Full-Service CRO offering end-to-end clinical research delivery; a Functional Service Provider (FSP) arrangement combining flexibility with therapeutic expertise; and Resourcing Solutions, covering staffing and resourcing for clinical research. Excelya positions these as parts of a one-stop provider model, with bespoke clinical trial solutions tailored to individual clients.
By the company's account, more than 550 clinical studies have been completed, including 71 oncology studies in three years, drawing on a collective 40 years of experience across therapeutic areas. Excelya was founded by engineers François Moisson and Frédéric Paqueville, and describes its culture around three core values: Energy, Care and Audacity, together with a patient-centered approach and a collaborative partnership style with clients.
